George Howard
George Howard
Dr. George Howard is Professor of Biostatistics at the UAB. He received his training in biostatistics was from the University of North Carolina at Chapel Hill. He has had experience in biostatistics, data management, and the direction of coordinating centers of multicenter studies.
Dr. George Howard is Professor of Biostatistics at the UAB. He received his training in biostatistics was from the University of North Carolina at Chapel Hill. He has had experience in biostatistics, data management, and the direction of coordinating centers of multicenter studies. He is currently the overall project PI for the REasons for Geographic and Racial Differences in Stroke (REGARDS) project, a U.S. national study developing a cohort of over 30,000 individuals to provide insights to the excess stroke mortality among African Americans and Southerners. He is also the PI of the Statistical and Data Management Center for the Carotid Revascularization for Primary Prevention of Stroke Trial (CREST-2), a pair of randomized trials each with an anticipated sample size of 1,240 that assess: 1) the difference between carotid endarterectomy versus intensive medical management, and 2) between carotid stenting and intensive medical management. He is also the immediate past PI of the Coordinating Centers the Carotid Revascularization Endarterectomy Stenting Trial (CREST) a randomized trial of 2,502 patients contrasting endarterectomy versus carotid stenting, Secondary Prevention of Small Subcortical Strokes (SPS3) a 2-by-2 factorial randomized trial of 3,000 lacunar stroke patients assessing aspirin versus clopidogrel and standard versus intensive blood pressure management, and the Trial of Early Aggressive Treatment of Rheumatoid Arthritis (TEAR) Trial a 2-by-2 factorial randomized trial of 750 patients with early arthritis assessing triple therapy versus an anti-TNF inhibitor and early versus late therapy. He was previously the PI of the Coordinating Center for the Insulin Resistance Atherosclerosis Study (IRAS), the Autoimmune Ear Disease (AIED) Study, and the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT). He has more than 320 publications, primarily in the analysis of cerebrovascular and cardiovascular risk factors, and has over 30 years experience working directly with clinical investigators.
 
FOUNDING PARTNERS:






Lipid and Blood Pressure
Meta-analysis Collaboration Group
Zeromskiego 113
90-549 Lodz, Poland
Phone/Fax: +48 42 639 37 71
Email: maciej.banach@umed.lodz.pl
© 2018 LBPMC. All rights reserved.